School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Jim Zhong

  • Department of Radiation Oncology
    Associate Professor
  • jim.zhong@emory.edu
Head shot of Jim Zhong

Overview

Jim Zhong, MD, is a board certified radiation oncologist specializing in the treatment of central nervous system malignancies, including brain and spine tumors, and head and neck cancer. He treats patients at Winship Cancer Institute's Clifton campus and Emory Proton Therapy Center.

Dr. Zhong graduated summa cum laude from Emory University, where he earned a BS in biology with highest honors. He subsequently completed medical school at Duke University School of Medicine in Durham, NC. After medical school, Dr. Zhong returned to his home city of Atlanta, GA to complete his Radiation Oncology Residency at Emory University. He was selected to serve as chief resident during his final year of residency training.

Dr. Zhong's research interest focuses on optimizing treatment outcomes for patients with malignant brain tumors, including glioblastomas, as well as the multidisciplinary management of brain metastases. He is currently the principal investigator of a study which seeks to evaluate treatment efficacy with focus on maximizing the quality of life in patients with brain metastases. He is a member of multiple professional organizations including the Society for Neuro-Oncology, the American Society for Radiation Oncology, and the American Society of Clinical Oncology.

During his training, Dr. Zhong earned several honors including the 2017 American Society of Clinical Oncology (ASCO) Conquer Foundation Merit Award and the Roentgen Resident/Fellow Research Award. He also received the honors of Phi Beta Kappa and the Barry M. Goldwater honorable mention during his attendance at Emory University.

Dr. Zhong has published and co-authored multiple manuscripts published in oncology journals such as Cancer, Neurosurgery, International Journal of Radiation Oncology, Biology, Physics, and Radiotherapy and Oncology.

Academic Appointment

  • Associate Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

  • MD from Duke University

Research

Publications

  • Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.
    Res Sq
    03/23/2023 Authors: Jansen CS; Prabhu RS; Pagadala MS; Chappa P; Goyal S; Zhou C; Neill SG; Prokhnevska N; Cardenas M; Hoang KB
  • Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
    Radiother Oncol Volume: 175 Page(s): 93 - 100
    10/01/2022 Authors: Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu H-KG
  • Modern Linear Accelerator-Based Radiotherapy Is Safe and Effective in the Treatment of Secretory and Nonsecretory Pituitary Adenomas.
    World Neurosurg Volume: 160 Page(s): e33 - e39
    04/01/2022 Authors: Janopaul-Naylor JR; Rupji M; Zhong J; Eaton BR; Ali N; Ioachimescu AG; Oyesiku NM; Shu H-KG
  • Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
    Pract Radiat Oncol Volume: 12 Page(s): 370 - 386
    01/01/2022 Authors: Halasz LM; Attia A; Bradfield L; Brat DJ; Kirkpatrick JP; Laack NN; Lalani N; Lebow ES; Liu AK; Niemeier HM
  • A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
    Neurooncol Adv Volume: 4 Page(s): vdac006
    01/01/2022 Authors: Ramesh K; Mellon EA; Gurbani SS; Weinberg BD; Schreibmann E; Sheriff SA; Goryawala M; de le Fuente M; Eaton BR; Zhong J
  • Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Lancet Oncol Volume: 22 Page(s): 1777 - 1786
    12/01/2021 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM
  • TREATMENT TRENDS AND SURVIVAL OUTCOMES IN ATYPICAL MENINGIOMA
    Volume: 23 Page(s): 48 - 48
    11/01/2021 Authors: Syed Y; Rupji M; Switchenko J; Eaton B; Olson J; Kimberly H; Bray D; Shu H-K; Zhong J
  • Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
    Cureus Volume: 13 Page(s): e19777
    11/01/2021 Authors: Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu H-K; Olson J; Hoang K
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases
    Volume: 111 Page(s): S25 - S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
    J Neurooncol Volume: 153 Page(s): 303 - 311
    06/01/2021 Authors: Zhong J; Huang V; Gurbani SS; Ramesh K; Scott Cordova J; Schreibmann E; Shu H-KG; Olson J; Han H; Giuffrida A
  • An immunologic niche of antigen presenting cells and stem-like CD8+T-cells is present in non-small cell lung cancer brain metastases.
    Volume: 27
    04/01/2021 Authors: Jansen CS; del Balzo L; Prabhu R; Logan S; Chappa P; Patel K; Wilkinson S; Lake R; Shu H-KG; Zhong J
  • Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
    Clin Transl Radiat Oncol Volume: 26 Page(s): 30 - 34
    01/01/2021 Authors: Janopaul-Naylor JR; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
  • Bladder Preserving Chemoradiotherapy Compared To Surgery For Variants Of Urothelial Carcinoma And Tumors With Divergent Differentiation: An Analysis Of The National Cancer Database
    Volume: 108 Page(s): E887 - E888
    11/01/2020 Authors: Janopaul-Naylor J; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
  • Robustness of a New Gradient Match Method in Intensity Modulated Proton Therapy of Craniospinal Irradiation (CSI) Using Independent Isocenter Setup
    Volume: 108 Page(s): E690 - E691
    11/01/2020 Authors: Zhou J; Wang Y; Gartin C; Matthews A; Esiashvili N; Shu HKG; Zhong J; McDonald MW; Liu T; Eaton BR
  • Proton Radiation Is Associated With Reduced Lymphocyte-Depleting Blood Volume In Glioblastoma Treatment
    Volume: 108 Page(s): E688 - E689
    11/01/2020 Authors: Buchwald ZS; Dang Q; Zhou J; Eaton BR; Shu HKG; Zhong J
  • Malignant seeding of the biopsy needle tract outside of the radiation therapy field in a patient with Glioblastoma.
    BJR Case Rep Volume: 6 Page(s): 20190070
    09/01/2020 Authors: Cooper ME; Zhong J; Kim S; Hoch MJ; Weinberg BD
  • Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Cancer Volume: 126 Page(s): 3255 - 3264
    07/15/2020 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD
  • Evolving role of biomaterials in diagnostic and therapeutic radiation oncology.
    Bioact Mater Volume: 5 Page(s): 233 - 240
    06/01/2020 Authors: Shi S; Vissapragada R; Abi Jaoude J; Huang C; Mittal A; Liu E; Zhong J; Kumar V
  • Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
    Sci Rep Volume: 10 Page(s): 7355
    04/30/2020 Authors: Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J
  • Outcomes of whole-brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases.
    J Neurooncol Volume: 147 Page(s): 117 - 123
    03/01/2020 Authors: Zhong J; Waldman AD; Kandula S; Eaton BR; Prabhu RS; Huff SB; Shu H-KG
  • Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.
    Adv Radiat Oncol Volume: 5 Page(s): 1147 - 1151
    01/01/2020 Authors: Dhere VR; Tian S; Buchwald Z; Jiang X; Zhang C; Chen Z; Eaton BR; Shu H-KG; Curran WJ; Zhong J
  • Hypofractionated Radiation for Benign Meningiomas and Vestibular Schwannomas
    Volume: 105 Page(s): E97 - E97
    09/01/2019 Authors: Dhere VR; Sudmeier LJ; Buchwald ZS; Tian S; Jiang X; Zhang C; Chen Z; Eaton BR; Shu HKG; Crocker IR
  • The Role of Standard and Advanced Imaging for the Management of Brain Malignancies From a Radiation Oncology Standpoint.
    Neurosurgery Volume: 85 Page(s): 165 - 179
    08/01/2019 Authors: Press RH; Zhong J; Gurbani SS; Weinberg BD; Eaton BR; Shim H; Shu H-KG
  • A Novel Method of Generating Synthetic CT From MRI for Proton Treatment Planning for Base of Skull Tumors
    Volume: 46 Page(s): E474 - E474
    06/01/2019 Authors: Shafai-Erfani G; Lei Y; Zhou J; Tian Z; Zhong J; Wang T; McDonald M; Curran W; Liu T; Shu H
  • The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
    Volume: 37
    05/20/2019 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan T; Behera M; Sengupta S; Voloschin AD
  • MRI-based synthetic CT generation using semantic random forest with iterative refinement.
    Phys Med Biol Volume: 64 Page(s): 085001
    04/05/2019 Authors: Lei Y; Harms J; Wang T; Tian S; Zhou J; Shu H-K; Zhong J; Mao H; Curran WJ; Liu T
  • Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.
    Laryngoscope Volume: 129 Page(s): 377 - 386
    02/01/2019 Authors: Cassidy RJ; Switchenko JM; El-Deiry MW; Belcher RH; Zhong J; Steuer CE; Saba NF; McDonald MW; Yu DS; Gillespie TW
  • Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162].
    Crit Rev Oncol Hematol Volume: 134 Page(s): 71
    02/01/2019 Authors: ShreeMahadevan L; Zhong J; Venkatesulu B; Kaur H; Bhide S; Minsky B; Chu W; Intven M; van der Heide UA; Triest B
  • MRI-Based Proton Treatment Planning for Base of Skull Tumors.
    Int J Part Ther Volume: 6 Page(s): 12 - 25
    01/01/2019 Authors: Shafai-Erfani G; Lei Y; Liu Y; Wang Y; Wang T; Zhong J; Liu T; McDonald M; Curran WJ; Zhou J
  • Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Volume: 42 Page(s): 36 - 41
    01/01/2019 Authors: Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B
  • The use of Hypofractionated Radiosurgery for the Treatment of Intracranial Lesions Unsuitable for Single-Fraction Radiosurgery.
    Neurosurgery Volume: 83 Page(s): 850 - 857
    11/01/2018 Authors: Zhong J; Press RH; Olson JJ; Oyesiku NM; Shu H-KG; Eaton BR
  • The addition of chemotherapy in the definitive management of high risk prostate cancer.
    Urol Oncol Volume: 36 Page(s): 475 - 487
    11/01/2018 Authors: Ferris MJ; Liu Y; Ao J; Zhong J; Abugideiri M; Gillespie TW; Carthon BC; Bilen MA; Kucuk O; Jani AB
  • Outcomes and Practice Patterns for Aggressive Local Therapy in Newly Diagnosed Stage IV Soft Tissue Sarcoma: An NCDB Analysis
    Volume: 102 Page(s): E228 - E229
    11/01/2018 Authors: Abugideiri M; Switchenko J; Tian S; Madden NA; Press RH; Buchwald ZS; Zhong J; Jhaveri J; Ferris MJ; Behera M
  • Outcomes of Whole Brain Radiation with Simultaneous In-Field Boost (SIB) for the Treatment of Brain Metastases
    Volume: 102 Page(s): E381 - E381
    11/01/2018 Authors: Zhong J; Waldman A; Kandula S; Eaton BR; Prabhu RS; Huff SB; Crocker IR; Shu HKG
  • Imaging predictors of treatment outcomes in rectal cancer: An overview.
    Crit Rev Oncol Hematol Volume: 129 Page(s): 153 - 162
    09/01/2018 Authors: Mahadevan LS; Zhong J; Venkatesulu B; Kaur H; Bhide S; Minsky B; Chu W; Intven M; van der Heide UA; van Triest B
  • Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
    Cancer Volume: 124 Page(s): 3586 - 3595
    09/01/2018 Authors: Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS
  • Correlation of genomic copy number variation with survival outcomes in high-grade glioma patients
    Volume: 36
    05/20/2018 Authors: Buchwald Z; Rossi MR; Smith G; Switchenko JM; Hauenstein J; Zhong J; Press RH; Tian S; Saxe D; Neill S
  • Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer.
    Ann Surg Oncol Volume: 25 Page(s): 1026 - 1033
    04/01/2018 Authors: Zhong J; Switchenko J; Behera M; Kooby D; Maithel SK; McDonald MW; Lin JY; Cassidy RJ; El-Rayes B; Landry J
  • Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas
    Volume: 100 Page(s): 1382 - 1382
    04/01/2018 Authors: Cassidy RJ; Switchenko J; El-Deiry MW; Belcher RH; Zhong J; Steuer C; Saba NF; McDonald MW; Yu DS; Gillespie T
  • Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.
    J Neurooncol Volume: 136 Page(s): 289 - 298
    01/01/2018 Authors: Chowdhary M; Okwan-Duodu D; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Zhong J; Chapman BV; Bindra RS; Contessa JN
  • Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy.
    Pract Radiat Oncol Volume: 8 Page(s): e125 - e131
    01/01/2018 Authors: Cassidy RJ; Nour SG; Liu T; Switchenko JM; Tian S; Ferris MJ; Press RH; Zhong J; Abugideiri M; Rossi PJ
  • Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy.
    Radiother Oncol Volume: 126 Page(s): 100 - 106
    01/01/2018 Authors: Ferris MJ; Zhong J; Switchenko JM; Higgins KA; Cassidy RJ; McDonald MW; Eaton BR; Patel KR; Steuer CE; Baddour HM
  • SPECTROSCOPIC MRI PREDICTS RECURRENCE PATTERNS IN GLIOBLASTOMA
    Volume: 19 Page(s): 219 - 219
    11/01/2017 Authors: Gurbani S; Kleinberg L; Zhong J; Holder CA; Olson JJ; Mellon E; Maudsley A; Shu H-K; Shim H
  • KRAS Mutant Non-small Cell Lung Cancer is Associated With Increased Risk of Salvage Whole Brain Radiation after Stereotactic Radiosurgery for Brain Metastases
    Volume: 99 Page(s): E100 - E101
    10/01/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer C; Pillai R; Owonikoko TK; Ramalingam S; Patel PR
  • Reproducibility in Contouring the Neurovascular Bundle for Prostate Cancer Radiotherapy Treatment Planning
    Volume: 99 Page(s): S109 - S110
    10/01/2017 Authors: Cassidy RJ; Nour SG; Liu T; Switchenko J; Zhong J; Tian S; Ferris MJ; Press RH; Abugideiri M; Rossi PJ
  • The Addition of Chemotherapy to Radical Prostatectomy for Management of High-Risk Prostate Cancer: A National Cancer Database Analysis
    Volume: 99 Page(s): E231 - E231
    10/01/2017 Authors: Ferris MJ; Liu Y; Ao J; Zhong J; Gillespie T; Jani A
  • Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Cancer Volume: 123 Page(s): 3486 - 3493
    09/15/2017 Authors: Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
  • Presence of genetic aberrations in patients with brain metastases from non-small cell lung cancer (NSCLC) and clinical outcomes
    Volume: 35
    05/20/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Patel PR
  • Chemotherapy with or without definitive radiation therapy in locally advanced pancreatic cancer.
    Volume: 35
    05/20/2017 Authors: Zhong J; Switchenko JM; Behera M; Kooby DA; McDonald MW; El-Rayes BF; Landry JC; Patel PR
  • Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cancer Volume: 123 Page(s): 783 - 793
    03/01/2017 Authors: Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
  • Comparison of outcomes in patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy (SBRT) versus conventionally fractionated radiation: An analysis of the National Cancer Database.
    Volume: 35
    02/01/2017 Authors: Zhong J; Patel KR; Switchenko JM; Gillespie TW; Cassidy RJ; Kooby DA; Landry JC
  • Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    J Neurooncol Volume: 131 Page(s): 611 - 618
    02/01/2017 Authors: Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ
  • The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.
    Volume: 123 Page(s): 512 - 520
    02/01/2017 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Cassidy RJ; Gillespie T; Kucuk O; Rossi P; Master VA; Alemozaffar M
  • Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Pract Radiat Oncol Volume: 7 Page(s): e419 - e425
    01/01/2017 Authors: Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu H-KG; Crocker IR
  • Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.
    Tomography Volume: 2 Page(s): 366 - 373
    12/01/2016 Authors: Cordova JS; Kandula S; Gurbani S; Zhong J; Tejani M; Kayode O; Patel K; Prabhu R; Schreibmann E; Crocker I
  • CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer
    Volume: 96 Page(s): E357 - E357
    10/01/2016 Authors: Ferris MJ; Zhong J; Switchenko J; Higgins KA; McDonald MW; Eaton BR; Miller AH; Bruner DW; Xiao C; Beitler JJ
  • Survival Impact of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemoradiation Therapy for Patients With T2N1, T3N0, and T3N1 Rectal Adenocarcinomas
    Volume: 96 Page(s): E148 - E148
    10/01/2016 Authors: Cassidy RJ; Liu Y; Zhong J; Gillespie TW; Landry JC
  • Patterns of Radiation Therapy Boost Administration in 356,160 Breast Cancer Patients Treated With Hypofractionated Versus Conventional Whole-Breast Irradiation.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E2 - E3
    10/01/2016 Authors: Zhong J; Kandula S; Liu X; Cassidy RJ; Gillespie TW; Liu Y; Torres M
  • Survival Impact of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemoradiation Therapy for Patients With T2N1, T3N0, and T3N1 Rectal Adenocarcinomas.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E148
    10/01/2016 Authors: Cassidy RJ; Liu Y; Zhong J; Gillespie TW; Landry JC
  • Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative Whole-Brain Radiation Therapy (WBRT) for Resectable Brain Metastases: A Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E85 - E86
    10/01/2016 Authors: Patel K; Burri SH; Symanowski J; Boselli D; Sumrall A; Press RH; Fraser RW; Zhong J; Olson JJ; Curran WJ
  • Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S93 - S94
    10/01/2016 Authors: Zhong J; Switchenko J; Jegadeesh N; Gillespie TW; Master VA; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP
  • CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E357
    10/01/2016 Authors: Ferris MJ; Zhong J; Switchenko J; Higgins KA; McDonald MW; Eaton BR; Miller AH; Bruner DW; Xiao C; Beitler JJ
  • Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Neurosurgery Volume: 79 Page(s): 279 - 285
    08/01/2016 Authors: Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH
  • The role of adjuvant radiotherapy in pathologically node positive prostate cancer
    Volume: 34
    01/10/2016 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Gillespie TW; Kucuk O; Rossi PJ; Master VA; Alemozaffar M; Jani AB
  • Impact of Angiotensin Blockade on Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery
    Volume: 93 Page(s): E360 - E360
    11/01/2015 Authors: Okwan-Duodu D; Patel K; Zhong J; Prabhu RS; Eaton BR; Olson J; Shu HKG; Curran WJ; Crocker IR
  • Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
    Cancer Volume: 121 Page(s): 1456 - 1462
    05/01/2015 Authors: Zhong J; Ali AN; Voloschin AD; Liu Y; Curran WJ; Crocker IR; Shu H-KG
  • BEVACIZUMAB-INDUCED HYPERTENSION IS A PREDICTIVE MARKER FOR IMPROVED OUTCOMES IN RECURRENT GLIOBLASTOMA
    NEURO-ONCOLOGY Volume: 16
    11/01/2014 Authors: Zhong J; Ali A; Voloschin A; Liu Y; Curran W; Crocker I; Shu H-K
  • A targeted genetic modifier screen links the SWI2/SNF2 protein domino to growth and autophagy genes in Drosophila melanogaster.
    G3 (Bethesda) Volume: 3 Page(s): 815 - 825
    05/20/2013 Authors: Kwon MH; Callaway H; Zhong J; Yedvobnick B
  • Targeted gain-of-function screening in Drosophila using GAL4-UAS and random transposon insertions.
    Genet Res (Camb) Volume: 91 Page(s): 243 - 258
    08/01/2009 Authors: Zhong J; Yedvobnick B
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements